Abstract
With the aim to reduce dosing frequency and to target drugs to cellular compartments actually in need of treatment, the design of drug delivery systems is becoming complementary to new drug discovery. The review highlights various drug/antigen delivery approaches comprising of vesicular and particulate nanocarriers that are associated with spectacular advantages like improved solubility and stability for poorly soluble drugs, good safety profile, versatility for encapsulating nearly all drugs, drug-release modulation, high drug payloads etc. In this review, light is shed on the remarkable potential of nanotechnology to provide more effective therapeutic and prophylactic approaches for the treatment and prevention for HIV/AIDS.
Keywords: Antiretroviral, drug delivery, nanocarriers, particulate drug delivery, vesicular drug delivery.
Graphical Abstract
Pharmaceutical Nanotechnology
Title:Nanocarrier based Antiretroviral Drug Delivery Approaches
Volume: 1 Issue: 4
Author(s): Sakshi Taneja and Kapil Khatri
Affiliation:
Keywords: Antiretroviral, drug delivery, nanocarriers, particulate drug delivery, vesicular drug delivery.
Abstract: With the aim to reduce dosing frequency and to target drugs to cellular compartments actually in need of treatment, the design of drug delivery systems is becoming complementary to new drug discovery. The review highlights various drug/antigen delivery approaches comprising of vesicular and particulate nanocarriers that are associated with spectacular advantages like improved solubility and stability for poorly soluble drugs, good safety profile, versatility for encapsulating nearly all drugs, drug-release modulation, high drug payloads etc. In this review, light is shed on the remarkable potential of nanotechnology to provide more effective therapeutic and prophylactic approaches for the treatment and prevention for HIV/AIDS.
Export Options
About this article
Cite this article as:
Taneja Sakshi and Khatri Kapil, Nanocarrier based Antiretroviral Drug Delivery Approaches, Pharmaceutical Nanotechnology 2013; 1 (4) . https://dx.doi.org/10.2174/22117385113016660007
DOI https://dx.doi.org/10.2174/22117385113016660007 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Reviews on Recent Clinical Trials Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Complex 3D Models to Study Drug Targeting of Invadopodia
Clinical Cancer Drugs Second Generation Adeno-Associated Virus Type 2-based Gene Therapy Systems with the Potential for Preferential Integration into AAVS1
Current Gene Therapy Contrast Enhanced Ultrasonography for Focal Liver Lesions Characterization: Clinical Perspective
Current Medical Imaging The Physiological Basis and Nutritional Function of Alpha-ketoglutarate
Current Protein & Peptide Science When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
Current Pharmaceutical Design Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Current Pharmaceutical Design Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents
Current Medicinal Chemistry Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets Radiolabeled Compounds in the Development of Cytotoxic Agents
Current Pharmaceutical Design Regulation of Tumor Angiogenesis by the Immune System
Current Angiogenesis (Discontinued) Association of Gag Multimers with Filamentous Actin During Equine Infectious Anemia Virus Assembly
Current HIV Research Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy
Current Pharmaceutical Biotechnology The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives
Current Medicinal Chemistry UCLA’s Molecular Screening Shared Resource: Enhancing Small Molecule Discovery with Functional Genomics and New Technology
Combinatorial Chemistry & High Throughput Screening Advances in the Development of Anticancer HSP-based Vaccines
Current Medicinal Chemistry The Epigenetics of Breast Carcinogenesis and Metastasis
Current Genomics Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry Medicinal Plants and Cancer Chemoprevention
Current Drug Metabolism